LETTER
McQuade, R. A.; Crosby, G.; Taylor, L. A.; Billard, W.
Synthesis of Bis(diaryl)sulfones
733
L.; Delamano, J.; Gomes, A.; Lopez, C.; Tojo, G. J. Org.
Chem. 1996, 61, 1188. (k) Shkoor, M.; Riahi, A.; Fatunsin,
O.; Reinke, H.; Fischer, C.; Langer, P. Synthesis 2009, 2223.
(9) For a review of site-selective palladium(0)-catalyzed cross-
coupling reactions, see: Schröter, S.; Stock, C.; Bach, T.
Tetrahedron 2005, 61, 2245.
(10) For site-selective reactions of bis(triflates) of 2,4¢-dihydro-
xybenzophenones, see: (a) Nawaz, M.; Adeel, M.; Farooq,
M.; Langer, P. Synlett 2009, 2154. For reactions of the
bis(triflate) of methyl 2,5-dihydroxybenzoate, see:
(b) Nawaz, M.; Farooq, M.; Obaid-Ur-Rahman, A.; Khera,
R. A.; Villinger, A.; Langer, P. Synlett 2010, 150.
(11) Synthesis of 2,4¢-Bis(trifluoromethylsulfonyloxy)-
diphenylsulfone (2)
Bioorg. Med. Chem. Lett. 2002, 12, 791. (o) Wang, Y.;
Chackalamannil, S.; Hu, Z.; Clader, J. W.; Greenlee, W.;
Billard, W.; Binch, H.; Crosby, G.; Ruperto, V.; Duffy, R.
A.; McQuade, R.; Lachowicz, J. E. Bioorg. Med. Chem. Lett.
2000, 10, 2247. (p) Boyle, C. D.; Chackalamannil, S.; Chen,
L.-Y.; Dugar, S.; Pushpavanam, P.; Billard, W.; Binch, H.;
Crosby, G.; Cohen-Williams, M.; Coffin, V. L.; Duffy, R. A.
Bioorg. Med. Chem. Lett. 2000, 10, 2727. (q) Wang, Y.;
Chackalamannil, S.; Chang, W.; Greenlee, W.; Ruperto, V.;
Duffy, R. A.; McQuade, R.; Lachowicz, J. E. Bioorg. Med.
Chem. Lett. 2001, 11, 891. (r) Tagat, J. R.; McCombie, S.
W.; Steensma, R. W.; Lin, S.-I.; Nazareno, D. V.; Baroudy,
B.; Vantuno, N.; Xu, S.; Liu, J. Bioorg. Med. Chem. Lett.
2001, 11, 2143. (s) Boyle, C. D.; Chackalamannil, S.;
Clader, J. W.; Greenlee, W. J.; Josien, H. B.; Kaminski, J. J.;
Kozlowski, J. A.; McCombie, S. W.; Nazareno, D. V.;
Tagat, J. R.; Wang, Y. Bioorg. Med. Chem. Lett. 2001, 11,
2311. (t) Boyle, C. D.; Vice, S. F.; Campion, J.;
Chackalamannil, S.; Lankin, C. M.; McCombie, S. W.;
Billard, W.; Binch, H.; Crosby, G.; Williams, M.-C.; Coffin,
V. L. Bioorg. Med. Chem. Lett. 2002, 12, 3479. Histamine
H3-receptor antagonistic activity: (u)Sasse, A.; Ligneau, X.;
Sadek, B.; Elz, S.; Pertz, H. H.; Ganellin, C. R.; Arrang, J.-
M.; Schwartz, J.-C.; Schunack, W.; Stark, H. Arch. Pharm.
(Weinheim, Ger.) 2001, 334, 45. Antiprotozoal activity:
(v) Langler, R. F.; Paddock, R. L.; Thompson, D. B.;
Crandall, I.; Ciach, M.; Kain, K. C. Aust. J. Chem. 2003, 56,
1127. Binding to the human cannabinoid CB1 receptor:
(w) Lavey, B. J.; Kozlowski, J. A.; Hipkin, R. W.;
Gonsiorek, W.; Lundell, D. J.; Piwinski, J. J.; Narula, S.;
Lunn, C. A. Bioorg. Med. Chem. Lett. 2005, 15, 783.
Inhibition of the main protease of the recombinant SARS
coronavirus: (x) Lu, I.-L.; Mahindroo, N.; Liang, P.-H.;
Peng, Y.-H.; Kuo, C.-J.; Tsai, K.-C.; Hsieh, H.-P.; Chao,
Y.-S.; Wu, S.-Y. J. Med. Chem. 2006, 9, 5154.
To a solution of 1 (1.0 equiv) in CH2Cl2 (10 mL per 1 mmol
of 1) was added pyridine (4.0 equiv) at –78 °C under an
argon atmosphere. After stirring for 10 min, Tf2O (2.4 equiv)
was added at –78 °C. The mixture was allowed to warm to
0 °C and stirred for 4 h. The reaction mixture was filtered,
and the filtrate was concentrated in vacuo. The products of
the reaction mixture were isolated by rapid column
chromatography (flash silica gel, heptanes–EtOAc). Starting
with 1 (250 mg, 1.0 mmol), pyridine (0.32 mL, 4.0 mmol),
and Tf2O (0.40 mL, 2.4 mmol), compound 2 was isolated as
a white solid (416 mg, 81%), mp 112 °C.
1H NMR (300 MHz, CDCl3): d = 7.32–7.39 (m, 3 H, ArH),
7.50–7.56 (m, 1 H, ArH), 7.63–7.69 (m, 1 H, ArH), 7.99–
8.04 (m, 2 H, ArH), 8.21–8.24 (m, 1 H, ArH). 19F NMR (282
MHz, CDCl3): d = –73.2, –73.3 CF. 13C NMR (75 MHz,
CDCl3): d = 114. 5 (q, JCF = 324.2 Hz, CF3), 121.8 (q,
JCF = 324.2 Hz, CF3), 122.4, 122.5, 128.9, 131.1, 131.4
(CH), 133.3 (C), 136.4 (CH), 140.5, 146.5, 152.9 (C). IR
(KBr): n = 3104 (w), 1594 (w), 1484 (w), 1434 (s), 1404 (w),
1325 (m), 1272 (w), 1203 (s), 1161 (s), 1127 (s), 1089 (m),
1054 (m), 992 (w), 966 (w), 870 (s), 749 (s), 781 (m), 726
(m), 688 (m), 629 (m), 599 (s), 562 (s), 552 (s) cm–1. GC-MS
(EI, 70 eV): m/z (%) = 514 (44) [M]+, 317 (1), 273 (27), 225
(05), 209 (33), 177 (100), 155 (06), 115 (17). HRMS (EI, 70
eV): m/z calcd for C14H8F6O8S3: 514.39262; found: 514.
39351.
(2) Joseph, J. K.; Jain, S. L.; Sain, B. Synth. Commun. 2006, 36,
2743.
(3) (a) Chen, D.-W.; Kubiak, R. J.; Ashley, J. A.; Janda, K. D.
J. Chem. Soc., Perkin Trans. 1 2001, 21, 2796. (b)Marquie,
J.; Laporterie, A.; Dubac, J.; Roques, N.; Desmurs, J.-R.
J. Org. Chem. 2001, 66, 421. (c) Repichet, S.; Le Roux, C.;
Dubac, J. Tetrahedron Lett. 1999, 40, 9233. (d) Hajipour,
A. R.; Zarei, A.; Khazdooz, L.; Pourmousavi, S. A.;
Mirjalili, B. B. F.; Ruoho, A. E. Phosphorus, Sulfur Silicon
Relat. Elem. 2005, 180, 2029.
(12) General Procedure for the Synthesis of 4a–j, 5a–e, and
6a–c
A 1,4-dioxane solution of the arylboronic acid, K3PO4,
Pd(PPh3)4, and 2 or 5 was stirred at 110 °C for 4 h under
argon atmosphere. After cooling to 20 °C, a sat. aq solution
of NH4Cl was added. The organic and the aqueous layer
were separated, and the latter was extracted with CH2Cl2.
The combined organic layers were dried (Na2SO4), filtered,
and the filtrate was concentrated in vacuo. The residue was
purified by column chromatography.
(4) Woroshzow, V.; Kutschkarow, V. Zh. Obshch. Khim. 1949,
19, 1943; Chem. Abstr. 1950, 1922.
(5) Zhu, W.; Ma, D. J. Org. Chem. 2005, 70, 2696.
(6) Bandgar, B. P.; Bettigeri, S. V.; Phopase, J. Org. Lett. 2004,
6, 2105.
(13) 2,4¢-Bis(4-tolyl)diphenylsulfone (4b)
(7) Huang, F.; Batey, R. A. Tetrahedron 2007, 63, 7667.
(8) (a) Erian, A. W.; Issac, Y.; Sherif, S. M.; Mahmoud, F. F.
J. Chem. Soc., Perkin Trans. 1 2000, 3686. (b) Ogura, K.;
Takeda, M.; Xie, J. R.; Akazome, M.; Matsumoto, S.
Tetrahedron Lett. 2001, 42, 1923. (c) Matsumoto, S.;
Kumazawa, K.; Ogura, K. Bull. Chem. Soc. Jpn. 2003, 76,
2179. (d) Bianchi, L.; Dell’Erba, C.; Maccagno, M.;
Mugnoli, A.; Novi, M.; Petrillo, G.; Sancassan, F.; Tavani,
C. J. Org. Chem. 2003, 68, 5254. (e) Mutsuhiro, Y.;
Watanabe, M.; Furukawa, S. Chem. Pharm. Bull. 1990, 38,
902. (f) Padwa, A.; Gareau, Y.; Harrison, B.; Rodriguez, A.
J. Org. Chem. 1992, 57, 3540. (g) Hayakawa, K.;
Starting with 2 (205 mg, 0.4 mmol), K3PO4 (254 mg, 1.2
mmol), Pd(PPh3)4 (6 mol%), 4-methylphenylboronic acid
(136 mg, 1.0 mmol), and 1,4-dioxane (5 mL per 1 mmol of
2), compound 4b was isolated as a white solid (112 mg,
70%), mp 131 °C. 1H NMR (300 MHz, CDCl3): d = 2.29 (s,
3 H, CH3), 2.30 (s, 3 H, CH3), 6.77–6.80 (m, 2 H, ArH),
6.89–6.92 (m, 2 H, ArH), 7.11–7.20 (m, 6 H, ArH), 7.26–
7.33 (m, 2 H, ArH), 7.44–7.52 (m, 3 H, ArH), 8.31–8.35 (m,
1 H, ArH). 13C NMR (75 MHz, CDCl3): d = 21.2, 21.3
(CH3), 126.6, 127.1, 127.6, 127.8, 128.2, 128.5, 129.8,
130.0, 132.8, 132.9 (CH), 135.4, 136.5, 137.4, 138.5, 139.3,
140.1, 142.3, 145.3 (C). IR (KBr): n = 3058 (w), 2921 (w),
2854 (w), 1731 (w), 1613 (m), 1484 (m), 4163 (m), 1404
(m), 1392 (m), 1313 (s), 1247 (w), 1151 (s), 1091 (m), 959
(w), 820 (m), 757 (s), 670 (m), 585 (s), 532 (s) cm–1. GC-MS
(EI, 70 eV): m/z (%) = 398 (100) [M]+, 366 (2), 318 (22),
Nishiyama, H.; Kanematsu, K. J. Org. Chem. 1985, 50, 512.
(h) Nakayama, J.; Hirashima, A. J. Am. Chem. Soc. 1990,
112, 7648. (i) Hu, C.-M.; Hong, F.; Jiang, B.; Xu, Y.
J. Fluorine Chem. 1994, 66, 215. (j) Antelo, B.; Castedo,
Synlett 2010, No. 5, 731–734 © Thieme Stuttgart · New York